Reversal of multidrug resistance by the anti-malaria drug artesunate in the esophageal cancer Eca109/ABCG2 cell line

Oncology Letters

Volumn 6, Issue 5, 2013, Pages 1475-1481

  Liu, Liang ^a   Fu Zuo, Lian ^a   Wen Guo, Jian ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Esophageal cancer; Multidrug resistance

Indexed keywords

ARTESUNATE; BREAST CANCER RESISTANCE PROTEIN; DAUNORUBICIN; DOXORUBICIN; MESSENGER RNA; MITOXANTRONE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ESOPHAGUS CANCER; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84884477909     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1545     Document Type: Article

References (24)

1. Gamliel Z: Incidence, epidemiology, and etiology of esophageal cancer. Chest Surg Clin N Am 10: 441-450, 2000.
2. Mehta NG and Mehta M: Overcoming multidrug-resistance in cancer: statins offer a logical candidate. Med Hypotheses 74: 237-239, 2010.
3. Katayama R, Koike S, Sato S, Sugimoto Y, Tsuruo T and FujitaN: Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export. Cancer Sci 100: 2060-2068, 2009.
4. Gillet JP and Gottesman MM: Mechanisms of multidrug resistance in cancer. Methods Mol Biol 596: 47-76, 2010.
5. Fojo T and Coley HM: The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategies. Clin Breast Cancer 7: 749-756, 2007.
6. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
7. Gottesman MM, Ambudkar SV and Xia D: Structure of a multidrug transporter. Nat Biotechnol 27: 546-547, 2009.
8. Mao Q and Unadkat JD: Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J 7: E118-E133, 2005.
9. Liu HG, Pan YF, You J, Wang OC, Huang KT and ZhangXH: Expression of ABCG2 and its significance in colorectal cancer. Asian Pac J Cancer Prev 11: 845-848, 2010.
10. Shanks GD: For severe malaria, artesunate is the answer. Lancet376: 1621-1622, 2010.
11. Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M, Mørch K, Foroutan B, Suttorp N, Yürek S and FlickH: Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 17: 771-777, 2011.
12. Bello SO: Pre-referral artesunate in severe malaria. Lancet 373: 1762-1763, 2009.
13. Zeng Y, Ni X, Meng WT, Wen Q and Jia YQ: Inhibitive effect of artesunate on human lymphoblastic leukemia/lymphoma cells. Sichuan Da Xue Xue Bao Yi Xue Ban 40: 1038-1043, 2009 (InChinese).
14. 2/M cell cycle progression of tumour cells and budding yeast. Cancer Genomics Proteomics 7: 337-346, 2010.
15. Hamacher-Brady A, Stein HA, Turschner S, Toegel I, MoraR, Jennewein N, Efferth T, Eils R and Brady NR: Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. JBiol Chem 286: 6587-6601, 2011.
16. Michaelis M, Kleinschmidt MC, Barth S, Rothweiler F, GeilerJ, BreitlingR, Mayer B, Deubzer H, Witt O, Kreuter J, DoerrHW, CinatlJ and Cinatl J Jr: Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem Pharmacol 79: 130-136, 2010.
17. Efferth T, Giaisi M, Merling A, Krammer PH and Li-WeberM: Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One 2: e693, 2007.
18. Reungpatthanaphong P and Mankhetkorn S: Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines. Biol Pharm Bull 25: 1555-1561, 2002.
19. Haufroid V: Genetic Polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition. Curr Drug Targets 12: 631-646, 2011.
20. Shukla S, Ohnuma S and Ambudkar SV: Improving cancer chemotherapy with modulators of ABC drug transporters. Curr Drug Targets 12: 621-630, 2011.
21. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, RishiAK and Ross DD: A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95: 15665-15670, 1998.
22. Li J, Li ZN, Du YJ, Li XQ, Bao QL and Chen P: Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival. Clin Lung Cancer 10: 414-421, 2009.
23. Ni Z and Mao Q: ATP-binding cassette efflux transporters in human placenta. Curr Pharm Biotechnol 12: 674-685, 2011.
24. Poller B, Wagenaar E, Tang SC and Schinkel AH: Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier. Mol Pharm 8: 571-582, 2011.